SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-040230
Filing Date
2024-04-02
Accepted
2024-04-02 16:30:10
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-02

Document Format Files

Seq Description Document Type Size
1 ARS sndx-2024-04-02_ars.pdf ARS 1504678
  Complete submission text file 0000950170-24-040230.txt   2073349
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37708 | Film No.: 24814732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)